Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation – a nationwide cohort study

Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation – a nationwide cohort study

Abstract Background Use of oral anticoagulation therapy in patients with atrial fibrillation (AF) involves a trade-off between a reduced risk of ischemic stroke and an increased risk of bleeding events. Different anticoagulation therapies have different safety profiles and data on the societal costs...

Full description

Bibliographic Details
Main Authors: Marie Jakobsen, Christophe Kolodziejczyk, Eskild Klausen Fredslund, Peter Bo Poulsen, Lars Dybro, Søren Paaske Johnsen
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Health Services Research
Subjects:
Anticoagulants
Atrial fibrillation
Bleeding
Cost of illness
Costs
Propensity score matching
Online Access:http://link.springer.com/article/10.1186/s12913-017-2331-z

Internet

http://link.springer.com/article/10.1186/s12913-017-2331-z

Similar Items